Private Practice

Partner, Goldman Ismail Tomaselli Brennan & Baum LLP

Partner, Fulbright & Jaworski LLP (now Norton Rose Fulbright)

Associate, Fulbright & Jaworski LLP (now Norton Rose Fulbright)


University of Texas at Austin School of Law (J.D., with honors)

Indiana University at Bloomington School of Business (B.S., Accounting and Finance, with distinction,)


Bar & Court Admissions

United States Supreme Court

State of Texas

U.S. Court of Appeals for the Fifth Circuit

U.S. Court of Appeals for the Sixth Circuit

U.S. Court of Appeals for the Ninth Circuit

U.S. District Courts for the Eastern, Northern, Southern, and Western Districts of Texas

Photo of Joe W. Tomaselli, Jr.

Joe W. Tomaselli, Jr.

Partner / Dallas

“Joe Tomaselli is a terrific litigator who frequently represents major pharmaceutical and medical device clients in mass torts. Clients are quick to highlight Joe Tomaselli’s in-depth understanding of technical information and his ability to take cases to trial.” – Chambers USA (ranked 2009-2019)

“Joe Tomaselli Jr is recommended for his top-tier work in the product liability arena, standing out for his vast experience litigating” complex cases including “mass tort claims for major clients in the pharmaceutical sector.” - Who’s Who Legal (recognized 2016-2018)

Joe Tomaselli is a go-to litigator and master strategist renowned for developing and implementing winning scientific theories of the case on behalf of pharmaceutical and medical device manufacturers. Clients facing high profile mass tort cases routinely recruit Joe to join and lead science and medical expert teams where he marshals scientific evidence and theories, retains leading medical experts, handles key depositions and evidentiary hearings, and serves as trial counsel.

Joe’s successes securing favorable pre-trial resolutions and defense verdicts in a host of bet-the-company litigations have earned him a well-deserved reputation as one of the nation’s best products liability lawyers. As reported by Chambers USA: “Joe Tomaselli has an encyclopedic knowledge of the relevant facts and information” and “adds incredible value because of his business acumen and academic training.” “According to sources, he impresses by diving into the scientific literature and providing unique insight.” “Clients appreciate Joe Tomaselli for his responsiveness, intelligence and litigation skills.” The Legal 500 echoes these sentiments, reporting feedback that “the distinguished” Joe Tomaselli is "highly recommended: one of the best trial lawyers I have worked with.” According to LMG Life Sciences, Joe is known as one of “the top product liability attorneys in the United States.” 

Joe’s reputation goes beyond working up and trying complex cases. Companies defending products liability actions recognize that a well-developed, comprehensive, scientific theory of the case is critical not only for trial, but also for executing a winning Daubert and summary judgment strategy to either narrow the case or avoid trial altogether. Joe is a proven national leader in this area. In addition, Joe excels in leveraging litigation theories and wins in designing global settlement programs that have efficiently disposed of thousands of cases nationwide. 

Of Note

Representative Litigation

SynchroMed Litigation

National counsel for Medtronic, Inc. in products liability cases nationwide involving the SynchroMed® II Programmable Drug Infusion System.

Rowley v. AbbVie, Inc.

Represented AbbVie in a MDL bellwether trial where the plaintiff claimed AndroGel caused his deep vein thrombosis. The jury returned a complete defense verdict for AbbVie in June 2018.

Sybron Canada Holdings, Inc. et al. v. Niznick et al.

Lead trial counsel for Danaher Corp. joint venture companies in a breach of contract and fiduciary duty action against the joint ventures’ minority shareholders pending in New York state court’s Commercial Division. After approximately fifty days of deposition testimony and a two-week bench trial, the Court granted complete relief to Danaher and the joint venture companies, ruling that the minority shareholders had engaged in conduct that triggered two contractual buy-out options.  The Court also rejected all of the minority shareholders’ counterclaims against Danaher and the joint venture companies from which the shareholders had originally sought over 100 million dollars in damages.   Obtained dismissal of two related cases filed in California state court by the minority shareholders.

Vioxx Litigation

Trial counsel, national expert team member, and global settlement program co-designer and implementer for Merck in products liability and government investigation matters arising out of the withdrawal of the prescription drug, Vioxx®.

In re Ethicon, Inc., Pelvic Repair System Products Liability Litigation

Member of national science and expert team for Johnson & Johnson and Ethicon in federal MDL concerning prescription pelvic mesh products used for the treatment of pelvic organ prolapse and stress incontinence.

Lyles et al v. McNeil-PPC, Inc. et al.

Trial counsel for McNeil and Johnson & Johnson in products liability case involving teenager’s fatal liver failure allegedly caused by Tylenol®. The matter settled for a nominal sum on the first day of trial. 

Berg v. Johnson & Johnson, et al.

Trial counsel for Imerys Talc America, Inc. in products liability case involving ovarian cancer. Court granted summary judgment to Imerys shortly before trial.

In re Hormone Therapy Litigation

Represented Wyeth in product liability litigation involving Premarin® and Prempro® hormone replacement therapy products alleged to cause breast cancer

Seroquel Litigation

Counsel and member of national expert team for AstraZeneca in products liability matters relating to the prescription drug, Seroquel® used to treat certain mental health disorders.

In re Medtronic, Inc. Sprint Fidelis Leads Products Liability Litigation

National counsel and expert team member for Medtronic in mass tort litigation regarding Medtronic’s Sprint Fidelis® heart defibrillator leads subject to product recall.